Paul Krüger

662 total citations
16 papers, 386 citations indexed

About

Paul Krüger is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Paul Krüger has authored 16 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 4 papers in Surgery. Recurrent topics in Paul Krüger's work include Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Paul Krüger is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Paul Krüger collaborates with scholars based in Australia, Canada and Germany. Paul Krüger's co-authors include John W. Eikelboom, James D. Douketis, Graeme J. Hankey, Norbert Hosten, Scott B. Reeder, Julia Mayerle, Till Ittermann, Birger Mensel, Jens‐Peter Kühn and Diego Hernando and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Paul Krüger

16 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Krüger Australia 9 139 99 87 68 67 16 386
Jayesh Jani United States 9 245 1.8× 144 1.5× 68 0.8× 125 1.8× 23 0.3× 15 491
Jahan C. Penny‐Dimri Australia 14 26 0.2× 134 1.4× 80 0.9× 105 1.5× 26 0.4× 36 446
IJ Mackie United Kingdom 13 110 0.8× 90 0.9× 19 0.2× 149 2.2× 72 1.1× 38 577
John R. Stringham United States 12 45 0.3× 48 0.5× 43 0.5× 123 1.8× 105 1.6× 20 507
Paula F. Ypma Netherlands 15 121 0.9× 162 1.6× 63 0.7× 63 0.9× 54 0.8× 57 770
Alex Gatt Malta 14 190 1.4× 146 1.5× 107 1.2× 133 2.0× 21 0.3× 39 750
Rachel S. Bercovitz United States 13 46 0.3× 31 0.3× 83 1.0× 82 1.2× 317 4.7× 35 671
Irwin Walker Canada 10 137 1.0× 63 0.6× 31 0.4× 96 1.4× 31 0.5× 15 309
Leonard I. Boral United States 12 39 0.3× 40 0.4× 57 0.7× 56 0.8× 95 1.4× 26 403
Inga Hegemann Switzerland 13 74 0.5× 53 0.5× 13 0.1× 65 1.0× 180 2.7× 26 510

Countries citing papers authored by Paul Krüger

Since Specialization
Citations

This map shows the geographic impact of Paul Krüger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Krüger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Krüger more than expected).

Fields of papers citing papers by Paul Krüger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Krüger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Krüger. The network helps show where Paul Krüger may publish in the future.

Co-authorship network of co-authors of Paul Krüger

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Krüger. A scholar is included among the top collaborators of Paul Krüger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Krüger. Paul Krüger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Hirsh, Jack, Ke Xu, Vinai Bhagirath, et al.. (2020). Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review. Thrombosis and Haemostasis. 120(9). 1323–1329. 23 indexed citations
3.
Krüger, Paul, Tomasz J. Guzik, & John W. Eikelboom. (2019). How can the results of the COMPASS trial benefit patients with coronary or peripheral artery disease in Poland?. Kardiologia Polska. 77(7-8). 661–669. 8 indexed citations
4.
Krüger, Paul, John W. Eikelboom, James D. Douketis, & Graeme J. Hankey. (2019). Pulmonary embolism: update on diagnosis and management. The Medical Journal of Australia. 211(2). 82–87. 20 indexed citations
5.
Krüger, Paul, John W. Eikelboom, James D. Douketis, & Graeme J. Hankey. (2019). Deep vein thrombosis: update on diagnosis and management. The Medical Journal of Australia. 210(11). 516–524. 113 indexed citations
6.
Xu, Ke, Noel Chan, Quazi Ibrahim, et al.. (2019). Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis. Thrombosis and Haemostasis. 119(4). 668–674. 16 indexed citations
7.
Hirsh, Jack, Vinai Bhagirath, Jeffrey S. Ginsberg, et al.. (2018). Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada. Journal of Thrombosis and Thrombolysis. 46(3). 310–315. 3 indexed citations
8.
Xu, Ke, Noel Chan, Jack Hirsh, et al.. (2018). Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery. European Journal Of Haematology. 101(3). 362–367. 6 indexed citations
9.
Krüger, Paul, et al.. (2015). Answer to October 2015 Photo Quiz. Journal of Clinical Microbiology. 53(10). 3389–3389. 1 indexed citations
10.
Stachs, Oliver, Tobias Lindner, Jan Rieger, et al.. (2014). High resolution MR imaging of the human eye and orbit at 7T using a dedicated 6-channel eye coil - impact of an optoacoustic triggered MR protocol on imaging quality. Investigative Ophthalmology & Visual Science. 55(13). 5845–5845. 1 indexed citations
11.
Leahy, Michael F., Syed Aqif Mukhtar, Shannon L. Farmer, et al.. (2013). A pragmatic approach to embedding patient blood management in a tertiary hospital. Transfusion. 54(4). 1133–1145. 67 indexed citations
12.
Krüger, Paul, Norbert Hosten, Annette Zimpfer, et al.. (2013). Experimental Differentiation of Intraocular Masses Using Ultrahigh-Field Magnetic Resonance Imaging – A Case Series. PLoS ONE. 8(12). e81284–e81284. 9 indexed citations
13.
Kühn, Jens‐Peter, Diego Hernando, Birger Mensel, et al.. (2013). Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. Journal of Magnetic Resonance Imaging. 39(6). 1494–1501. 74 indexed citations
14.
Krüger, Paul, Julian Cooney, & J. Harvey Turner. (2012). Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 27(9). 552–560. 7 indexed citations
15.
Krüger, Paul, et al.. (2012). Prothrombinex‐VF use in warfarin reversal and other indications. The Medical Journal of Australia. 196(7). 462–465. 3 indexed citations
16.
Langner, Sönke, H. Martin, Thom Terwee, et al.. (2010). 7.1 T MRI to Assess the Anterior Segment of the Eye. Investigative Ophthalmology & Visual Science. 51(12). 6575–6575. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026